GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a camelised human vh

Analyse Crystal structure of a camelised human vh in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1OL0
Type
protein
Length
242 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Immunoglobulin G
Ligands
SO4
Pockets
1 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BImmunoglobulin Gprotein12110% helix, 48% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 5 copies · chains A, B
  • GOL · Glycerol · additive · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11170.440.7727GOL

Interfaces

1 interface between chains.

  • A–B · 742 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified, 2 disulfide (engineered, disulfide).

Compared structures

  • 1OL0 · Crystal structure of a camelised human VH · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.